| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Henderson John T is a Director at MYRIAD GENETICS INC with holdings across 2 companies. Recent SEC Form 4 filings include 5 buys and 14 sells.
Estimated insider holdings value: $6.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 1, 2021 | CYTK Cytokinetics Inc | Director | Sale+OE | 3,333 | $23.54 | $78,474.00 | -13.0% | -19.0% | +57.0% | |
| Dec 31, 2020 | CYTK Cytokinetics Inc | Director | Sale+OE | 858 | $20.31 | $17,425.98 | -48.8% | - | - | |
| Oct 5, 2020 | CYTK Cytokinetics Inc | Director | Sale+OE | 3,000 | $29.00 | $87,000.00 | -62.5% | - | - | |
| Nov 7, 2019 | MYGN Myriad Genetics Inc | Director | Buy | 7,000 | $23.46 | $164,222.80 | +11.8% | - | - | |
| Jul 11, 2018 | MYGN Myriad Genetics Inc | Director | Sale+OE | 30,000 | $42.06 | $1,261,785.00 | -16.7% | - | - | |
| Sep 1, 2017 | MYGN Myriad Genetics Inc | Director | Sale+OE | 30,000 | $30.30 | $909,040.00 | -19.0% | - | - | |
| Feb 23, 2017 | MYGN Myriad Genetics Inc | Director | Buy | 6,000 | $18.66 | $111,930.20 | +5.1% | - | - | |
| Sep 12, 2016 | MYGN Myriad Genetics Inc | Director | Sale+OE | 30,000 | $20.49 | $614,816.29 | -41.1% | - | - |